Can I read Long-Term Anticoagulation Discontinuation After Catheter Ablationfor Atrial FibrillationThe ALONE-AF Randomized Clinical Trial on EtoBox?

Long-Term Anticoagulation Discontinuation After Catheter Ablationfor Atrial FibrillationThe ALONE-AF Randomized Clinical Trial by Daehoon Kim, MD; Jaemin Shim, MD; Eue-Keun Choi, MD; Il-Young Oh, MD; Jun Kim, MD; Young Soo Lee, MD; is a book available to read on EtoBox.

What is Long-Term Anticoagulation Discontinuation After Catheter Ablationfor Atrial FibrillationThe ALONE-AF Randomized Clinical Trial about?

IMPORTANCE Data from randomized clinical trials on a long-term anticoagulation strategy forEditorialpatients after catheter-based ablation for atrial fibrillation (AF) are lacking.Supplemental contentOBJECTIVE To evaluate whether discontinuing oral anticoagulant therapy provides superiorclinical outcomes compared with continuing oral anticoagulant therapy in patients withoutdocumented atrial arrhythmia recurrence after catheter ablation for AF.DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial including 840 adult patients(aged 19-80 years) who were enrolled and randomized from July 28, 2020, to March 9, 2023,at 18 hospitals in South Korea. Enrolled patients had at least 1 non–sex-related stroke riskfactor (determined using the CHA2DS2-VASc score [range, 0-9]) and no documentedrecurrence of atrial arrhythmia for at least 1 year after catheter ablation for AF. TheCHA2DS2-VASc score is used as an assessment of stroke risk among patients with AF(calculated using point values for congestive heart failure, hypertension, 75 years of age,diabetes, stroke or transient ischemic attack, vascular disease, between 65 and 74 years ofage, and sex category). The date of final follow-up

Author

Daehoon Kim, MD; Jaemin Shim, MD; Eue-Keun Choi, MD; Il-Young Oh, MD; Jun Kim, MD; Young Soo Lee, MD;

Published

2025

Language

EN